Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision tag in the page footer was updated from v3.5.4 to v3.5.5, indicating a minor software update to the page.
    Difference
    0.1%
    Check dated 2026-06-05T21:43:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A clinical study report synopsis, sponsor-related items (AbbVie), and a new 'Helpful Links Provided by AbbVie' section were added, and the page revision was updated to v3.5.4.
    Difference
    0.2%
    Check dated 2026-05-15T14:13:19.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:01:33.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No changes to the page content or clinical information are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:50.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:42.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:22.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.